Is OXYCURE still active?

Yes, OXYCURE is currently active.

What does OXYCURE do?

OXYCURE's registered main activities are Activities in the field of nutrition and Retail sale of pharmaceutical products. It is also registered for 5 additional activities.

Where is OXYCURE registered?

OXYCURE's registered address is Rue Léopold Genicot, ZI, Nov. 9, 5380 Fernelmont, Belgium.

How many employees does OXYCURE have?

Based on its most recently filed annual accounts (fiscal year ending 30 Jun 2025), OXYCURE reported 60.1 full-time equivalent employees.

What is OXYCURE's annual turnover?

OXYCURE's most recently filed annual turnover (fiscal year ending 30 Jun 2025) was €13,834,574.

Did OXYCURE make a profit or a loss?

OXYCURE's most recently filed annual accounts (fiscal year ending 30 Jun 2025) reported a profit of €17,778.

When did OXYCURE last file annual accounts?

OXYCURE's most recently filed annual accounts cover the fiscal year ending 30 Jun 2025.

Is OXYCURE B Corp certified?

We have no B Corp certification on file for OXYCURE.

Does OXYCURE hold Fairtrade certification?

No, OXYCURE does not currently hold Fairtrade certification.

OXYCURE

Q: When was OXYCURE founded?

OXYCURE was founded on 28 May 1998, making it 28 years old.

BE 0463.450.459

Copied!

NV/SA

Status

Active

Founded

28 May 1998

Size

Medium · 60.1 FTE

Age

28 yrs

Main activity

Activities in the field of nutrition

Activities

7 activities

Activities in the field of nutritionRetail sale of pharmaceutical productsBusiness and other management consultancy activitiesRental and leasing of medical and paramedical equipmentWholesale of pharmaceutical and medical goodsManufacture of medicamentsRetail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses

Financials

Turnover2025

€13.8M-2.4%

Profit / Loss2025

€17.8K+106.9%

Equity2025

€2.4M+0.5%

2025	2024	2023	2022
€13,834,574-2.4%	€14,175,411+0.2%	€14,148,532+13.5%	€12,464,236
€17,778+106.9%	-€258,232+80.3%	-€1,311,074-180.9%	-€466,800
€2,419,198+0.5%	€2,406,808-9.8%	€2,667,561-32.3%	€3,942,910
€8,590,347-11.6%	€9,715,562+2.6%	€9,466,675-10.6%	€10,585,354
€1,041,753-1.8%	€1,060,837+102.8%	€523,199-38.7%	€853,785
60.1-2.9%	61.9-7.7%	67.1+30.5%	51.4
€230,193+0.5%	€229,005+8.6%	€210,857-13%	€242,495

Frequently asked questions

01What is OXYCURE's official registered name?

OXYCURE.

02What is OXYCURE's enterprise number (VAT number)?

BE 0463.450.459.

03What is OXYCURE's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

04When was OXYCURE founded?

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€13,834,574-2.4%	€14,175,411+0.2%	€14,148,532+13.5%	€12,464,236
	—	—	€7,083,081+16.6%	€6,074,174
	€4,365,783+0.7%	€4,336,984-7.2%	€4,671,286+33.2%	€3,508,172
	—	—	€1,679,702-52.2%	€3,513,571
	€275,141+379.5%	€57,380+104.4%	-€1,317,780-224.4%	-€406,206
	€2,896,804-8.7%	€3,173,053	—	—
	€2,635,120-8.1%	€2,868,972	—	—
	€17,778+106.9%	-€258,232+80.3%	-€1,311,074-180.9%	-€466,800
	€211,319-14.4%	€247,004+12.3%	€220,033-1%	€222,281
Profitability
	—	—	50.1%+2.7%	48.7%
	20.9%-6.5%	22.4%	—	—
	0.1%+107.1%	-1.8%+80.3%	-9.3%-147.4%	-3.7%
	0.7%+106.9%	-10.7%+78.2%	-49.1%-315.1%	-11.8%
	0.2%+107.6%	-2.1%+80.3%	-10.6%-235%	-3.2%
Solvency
	€11,215,786-9.1%	€12,332,9320%	€12,333,267-16.2%	€14,712,886
	€6,461,301-7.7%	€7,003,852-11%	€7,867,939-16.3%	€9,401,328
	€3,2800%	€3,280-1.5%	€3,3300%	€3,330
	€2,419,198+0.5%	€2,406,808-9.8%	€2,667,561-32.3%	€3,942,910
	21.6%+10.5%	19.5%-9.8%	21.6%-19.3%	26.8%
	€5,280,500-16.4%	€6,317,792+29.3%	€4,886,181-18.4%	€5,989,775
	2.18-16.8%	2.62+43.3%	1.83+20.6%	1.52
	€8,590,347-11.6%	€9,715,562+2.6%	€9,466,675-10.6%	€10,585,354
	3.55-12%	4.04+13.8%	3.55+32.2%	2.68
	1.05	—	—	—
Liquidity
	€1,041,753-1.8%	€1,060,837+102.8%	€523,199-38.7%	€853,785
	€372,808-1.8%	€379,542-20.6%	€478,063+87.7%	€254,745
	€2,452,049-16.3%	€2,931,063+14%	€2,572,225-9.5%	€2,843,761
	€955,243+27.4%	€749,783-52.1%	€1,564,708+36.4%	€1,147,292
	€3,309,197-1.2%	€3,350,087-26.7%	€4,572,115-0.1%	€4,578,492
	0.92-10.2%	1.03+42.1%	0.72-6.9%	0.78
	€780,789-32%	€1,148,521+253.1%	-€750,139-326.4%	-€175,941
Efficiency
	65 days-14.3%	75 days+13.7%	66 days-20.3%	83 days
	51 days+32.2%	39 days	—	—
	237 days+37.2%	173 days	—	—
	1.53-18.2%	1.87	—	—
Profit appropriation
	€99,7800%	€99,7800%	€99,7800%	€99,780
	€1,293,802+1.4%	€1,276,025-16.8%	€1,534,256-46.1%	€2,845,330

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€13,834,574-2.4%	€14,175,411+0.2%	€14,148,532+13.5%	€12,464,236
	—	—	€7,083,081+16.6%	€6,074,174
	€4,365,783+0.7%	€4,336,984-7.2%	€4,671,286+33.2%	€3,508,172
	—	—	€1,679,702-52.2%	€3,513,571
	€275,141+379.5%	€57,380+104.4%	-€1,317,780-224.4%	-€406,206
	€2,896,804-8.7%	€3,173,053	—	—
	€2,635,120-8.1%	€2,868,972	—	—
	€17,778+106.9%	-€258,232+80.3%	-€1,311,074-180.9%	-€466,800
	€211,319-14.4%	€247,004+12.3%	€220,033-1%	€222,281
Profitability
	—	—	50.1%+2.7%	48.7%
	20.9%-6.5%	22.4%	—	—
	0.1%+107.1%	-1.8%+80.3%	-9.3%-147.4%	-3.7%
	0.7%+106.9%	-10.7%+78.2%	-49.1%-315.1%	-11.8%
	0.2%+107.6%	-2.1%+80.3%	-10.6%-235%	-3.2%
Solvency
	€11,215,786-9.1%	€12,332,9320%	€12,333,267-16.2%	€14,712,886
	€6,461,301-7.7%	€7,003,852-11%	€7,867,939-16.3%	€9,401,328
	€3,2800%	€3,280-1.5%	€3,3300%	€3,330
	€2,419,198+0.5%	€2,406,808-9.8%	€2,667,561-32.3%	€3,942,910
	21.6%+10.5%	19.5%-9.8%	21.6%-19.3%	26.8%
	€5,280,500-16.4%	€6,317,792+29.3%	€4,886,181-18.4%	€5,989,775
	2.18-16.8%	2.62+43.3%	1.83+20.6%	1.52
	€8,590,347-11.6%	€9,715,562+2.6%	€9,466,675-10.6%	€10,585,354
	3.55-12%	4.04+13.8%	3.55+32.2%	2.68
	1.05	—	—	—
Liquidity
	€1,041,753-1.8%	€1,060,837+102.8%	€523,199-38.7%	€853,785
	€372,808-1.8%	€379,542-20.6%	€478,063+87.7%	€254,745
	€2,452,049-16.3%	€2,931,063+14%	€2,572,225-9.5%	€2,843,761
	€955,243+27.4%	€749,783-52.1%	€1,564,708+36.4%	€1,147,292
	€3,309,197-1.2%	€3,350,087-26.7%	€4,572,115-0.1%	€4,578,492
	0.92-10.2%	1.03+42.1%	0.72-6.9%	0.78
	€780,789-32%	€1,148,521+253.1%	-€750,139-326.4%	-€175,941
Efficiency
	65 days-14.3%	75 days+13.7%	66 days-20.3%	83 days
	51 days+32.2%	39 days	—	—
	237 days+37.2%	173 days	—	—
	1.53-18.2%	1.87	—	—
Profit appropriation
	€99,7800%	€99,7800%	€99,7800%	€99,780
	€1,293,802+1.4%	€1,276,025-16.8%	€1,534,256-46.1%	€2,845,330

2025

2024

2023

2022

Income statement

€13,834,574-2.4%

€14,175,411+0.2%

€14,148,532+13.5%

€12,464,236

—

€7,083,081+16.6%

€6,074,174

€4,365,783+0.7%

€4,336,984-7.2%

€4,671,286+33.2%

€3,508,172

—

€1,679,702-52.2%

€3,513,571

€275,141+379.5%

€57,380+104.4%

-€1,317,780-224.4%

-€406,206

€2,896,804-8.7%

€3,173,053

—

€2,635,120-8.1%

€2,868,972

—

€17,778+106.9%

-€258,232+80.3%

-€1,311,074-180.9%

-€466,800

€211,319-14.4%

€247,004+12.3%

€220,033-1%

€222,281

Profitability

—

50.1%+2.7%

48.7%

20.9%-6.5%

22.4%

—

0.1%+107.1%

-1.8%+80.3%

-9.3%-147.4%

-3.7%

0.7%+106.9%

-10.7%+78.2%

-49.1%-315.1%

-11.8%

0.2%+107.6%

-2.1%+80.3%

-10.6%-235%

-3.2%

Solvency

€11,215,786-9.1%

€12,332,9320%

€12,333,267-16.2%

€14,712,886

€6,461,301-7.7%

€7,003,852-11%

€7,867,939-16.3%

€9,401,328

€3,2800%

€3,280-1.5%

€3,3300%

€3,330

€2,419,198+0.5%

€2,406,808-9.8%

€2,667,561-32.3%

€3,942,910

21.6%+10.5%

19.5%-9.8%

21.6%-19.3%

26.8%

€5,280,500-16.4%

€6,317,792+29.3%

€4,886,181-18.4%

€5,989,775

2.18-16.8%

2.62+43.3%

1.83+20.6%

1.52

€8,590,347-11.6%

€9,715,562+2.6%

€9,466,675-10.6%

€10,585,354

3.55-12%

4.04+13.8%

3.55+32.2%

2.68

1.05

—

Liquidity

€1,041,753-1.8%

€1,060,837+102.8%

€523,199-38.7%

€853,785

€372,808-1.8%

€379,542-20.6%

€478,063+87.7%

€254,745

€2,452,049-16.3%

€2,931,063+14%

€2,572,225-9.5%

€2,843,761

€955,243+27.4%

€749,783-52.1%

€1,564,708+36.4%

€1,147,292

€3,309,197-1.2%

€3,350,087-26.7%

€4,572,115-0.1%

€4,578,492

0.92-10.2%

1.03+42.1%

0.72-6.9%

0.78

€780,789-32%

€1,148,521+253.1%

-€750,139-326.4%

-€175,941

Efficiency

65 days-14.3%

75 days+13.7%

66 days-20.3%

83 days

51 days+32.2%

39 days

—

237 days+37.2%

173 days

—

1.53-18.2%

1.87

—

Profit appropriation

€99,7800%

€99,780

€1,293,802+1.4%

€1,276,025-16.8%

€1,534,256-46.1%

€2,845,330

OXYCURE

Activities

Financials

Frequently asked questions

All locations

All locations